All PlansAdministrativeHigh impact
Voluntary nationwide recall: Sodium Chloride (B. Braun – August 2026)
UPMC Health Plan·Pharmacy·Pharmacy
We identified it
Sep 12, 2026
Summary
B. Braun Medical Inc. is recalling three lots of 0.9% Sodium Chloride Injection USP (100 mL) due to iron oxide particles in the solution that could cause local irritation, swelling, or life-threatening blood clots. The billing team must identify claims involving these recalled lots and coordinate with providers and patients to halt use and prevent billing for potentially harmful products.
Action Required
Immediately: Billing team must identify and flag any claims containing sodium chloride injections (HCPCS J7131 or similar saline codes) billed between the manufacture date of recalled lots (J6B435, J6B444, J6B457) and August 27, 2026. Coordinate with clinical staff and providers to verify which patients received recalled lots. Contact affected patients and providers to report the recall. Do not process claims for recalled product lots until verified as non-affected. Update internal tracking system to document recalled lot numbers and affected claims. Direct all inquiries to B. Braun recalls department (recalls@bbraunusa.com, Monday-Friday 8 a.m.-5 p.m. EST) or FDA website. Failure to identify and address recalled product use may result in patient harm claims, regulatory penalties, and claim denials if billed without disclosure.